You are here

Article Text

Article menu

Download PDFPDF

Clinical science
Changes observed in diabetic retinopathy: eight-year follow-up of a Spanish population
  1. Pedro Romero-Aroca1,
  2. Sofia de la Riva-Fernandez1,
  3. Aida Valls-Mateu2,
  4. Ramon Sagarra-Alamo3,
  5. Antonio Moreno-Ribas2,
  6. Nuria Soler1
  1. 1Ophthalmic Service, University Hospital Sant Joan, Institut de Investigacio Sanitaria Pere Virgili (IISPV), University Rovira & Virgili, Reus, Spain
  2. 2Department of Computer Engineering and Mathematics, University Rovira & Virgili, Reus, Spain
  3. 3Health Care Area Reus-Priorat, Institut Catala de la Salut (ICS), Institut de Investigacio Sanitaria Pere Virgili (IISPV), University Rovira & Virgili, Reus, Spain
  1. Correspondence to Dr Pedro Romero-Aroca, Hospital Universtario Sant Joan, Avenida Doctor Josep Laporte 2, C/Manresa 3, Reus 43204, Spain; romeropere{at}gmail.com/promero{at}grupsagessa.com

Abstract

Background/aims To determine the changes in the incidence of diabetic retinopathy (DR), diabetic macular oedema (DMO) and their risk factors in a population-based study of patients with diabetes mellitus (DM) referred to our 16 Primary Health Care Areas (HCAs).

Methods Prospective population-based study of a total of 15 396 Caucasian patients with DM, who represent 86.53% of the total patients with DM in our HCAs, were studied over an 8-year follow-up period. All patients were screened with a mean follow-up of 3.18±1.11 times for each patient over the 8 years.

Results The yearly mean value of any DR was 8.37±2.19% (8.09%–8.99%); of advanced DR yearly mean value of 0.46±0.22% (0.03–0.78); and of DMO a yearly mean value of 2.19±0.18% (2%–2.49%). A clear increase was observed in the last 3 years, any DR increased from 8.09% in 2007 to 8.99% in 2014, and DMO from 2% in 2007 to 2.49% in 2014. These increases were more evident in some age groups. For patients with any DR aged 41–50 and 51–60 and for patients with advanced DR aged 41–50, 51–60 and 61–70, the increase was more marked, related to an increase in HbA1c values or to patients treated with insulin.

Conclusions An increase in the incidence of DR and DMO was observed, especially in the younger patients aged between 31 and 70 years. This is linked to bad metabolic control of DM. Our results suggest a greater number of ocular complications in the near future, such as neovascular glaucoma, if these current findings are not addressed.

  • Epidemiology
  • Retina
  • Telemedicine
  • Macula
  • Public health

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

https://doi.org/10.1136/bjophthalmol-2015-307689

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Linked Articles

    • At a glance
      Highlights from this issue
      Keith Barton James Chodosh Jost Jonas
      British Journal of Ophthalmology 2016; 100 1-1 Published Online First: 22 Sep 2016. doi: 10.1136/bjophthalmol-2016-309597